Home LiteratureArticle Details
PMID: 8668206 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M.

Molecular and cellular biology ·Vol. 16 ·No. 7 ·1996-07-00 ·Pages 3884-92

Naumovski L, Cleary ML

Abstract

Using the yeast two-hybrid system, we have isolated a cDNA (designated BBP, for Bcl2-binding protein) for a protein (Bbp) that interacts with Bcl2. Bbp is identical to 53BP2, a partial clone of which was previously isolated in a two-hybrid screen for proteins that interact with p53. In this study, we show that specific interactions of Bbp/53BP2 with either Bcl2 or p53 require its ankyrin repeats and SH3 domain. These interactions can be reproduced in vitro with bacterially expressed fusion proteins, and competition experiments indicate that Bcl2 prevents p53 from binding to Bbp/53BP2. BBP/53BP2 mRNA is abundant in most cell lines examined, but the protein cannot be stably expressed in a variety of cell types by transfection. In transiently transfected cells, Bbp partially colocalizes with Bcl2 in the cytoplasm and results in an increased number of cells at G2/M, possibly accounting for the inability to obtain stable transfectants expressing the protein. These results demonstrate that a single protein can interact with either Bcl2 or p53 both in yeast cells and in vitro. The in vivo significance of these interactions and their potential consequences for cell cycle progression and cell death remain to be determined.

MeSH Terms
3T3 Cells Amino Acid Sequence Animals Ankyrin Repeat Apoptosis Apoptosis Regulatory Proteins Carrier Proteins/biosynthesis,metabolism Cell Cycle Cell Line Chlorocebus aethiops Cloning, Molecular Escherichia coli Glutathione Transferase/biosynthesis Mice Molecular Sequence Data Proto-Oncogene Proteins/metabolism Proto-Oncogene Proteins c-bcl-2 Recombinant Fusion Proteins/biosynthesis,metabolism Saccharomyces cerevisiae Sequence Tagged Sites Transfection Tumor Suppressor Protein p53/metabolism src Homology Domains
Chemicals
Apoptosis Regulatory Proteins Carrier Proteins Proto-Oncogene Proteins Proto-Oncogene Proteins c-bcl-2 Recombinant Fusion Proteins TP53BP2 protein, human Tumor Suppressor Protein p53 Glutathione Transferase
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Naumovski L
Department of Pediatrics, Division of Hematology/Oncology, Stanford University School of Medicine, California 94305, USA.
Cleary M L
References (60)
60 references, click to expand
  1. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2.
    Cell. 1994 Oct 21;79(2):329-39 PMID: 7954799
  2. Two cellular proteins that bind to wild-type but not mutant p53.
    Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6098-102 PMID: 8016121
  3. Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BP1, and 53BP2.
    Mol Cell Biol. 1994 Dec;14(12):8315-21 PMID: 7969167
  4. Evidence for a second cell cycle block at G2/M by p53.
    Oncogene. 1995 Jan 5;10(1):109-15 PMID: 7529916
  5. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death.
    Cell. 1995 Jan 27;80(2):285-91 PMID: 7834748
  6. A p53-dependent mouse spindle checkpoint.
    Science. 1995 Mar 3;267(5202):1353-6 PMID: 7871434
  7. Heterodimerization with Bax is required for Bcl-2 to repress cell death.
    Curr Top Microbiol Immunol. 1995;194:331-8 PMID: 7895506
  8. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K.
    Nature. 1995 Apr 20;374(6524):731-3 PMID: 7715729
  9. Induction of apoptosis by the Bcl-2 homologue Bak.
    Nature. 1995 Apr 20;374(6524):733-6 PMID: 7715730
  10. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak.
    Nature. 1995 Apr 20;374(6524):736-9 PMID: 7715731
  11. Accumulation of wild-type p53 protein upon gamma-irradiation induces a G2 arrest-dependent immunoglobulin kappa light chain gene expression.
    EMBO J. 1995 Apr 3;14(7):1392-401 PMID: 7729417
  12. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors.
    Proc Natl Acad Sci U S A. 1995 May 9;92(10):4407-11 PMID: 7753819
  13. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.
    Cell. 1985 Jul;41(3):899-906 PMID: 3924412
  14. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining.
    Science. 1985 Sep 27;229(4720):1390-3 PMID: 3929382
  15. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.
    Proc Natl Acad Sci U S A. 1985 Nov;82(21):7439-43 PMID: 2865728
  16. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.
    Cell. 1986 Oct 10;47(1):19-28 PMID: 2875799
  17. SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.
    Mol Cell Biol. 1988 Jan;8(1):466-72 PMID: 2827008
  18. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.
    Gene. 1988 Jul 15;67(1):31-40 PMID: 3047011
  19. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
    Nature. 1988 Sep 29;335(6189):440-2 PMID: 3262202
  20. Prediction of protein conformation.
    Biochemistry. 1974 Jan 15;13(2):222-45 PMID: 4358940
  21. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.
    Cell. 1989 Apr 7;57(1):79-88 PMID: 2649247
  22. The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation.
    Mol Cell Biol. 1989 Feb;9(2):701-10 PMID: 2651903
  23. A novel genetic system to detect protein-protein interactions.
    Nature. 1989 Jul 20;340(6230):245-6 PMID: 2547163
  24. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.
    J Immunol. 1990 May 1;144(9):3602-10 PMID: 2184193
  25. Basic local alignment search tool.
    J Mol Biol. 1990 Oct 5;215(3):403-10 PMID: 2231712
  26. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.
    Nature. 1990 Nov 22;348(6299):334-6 PMID: 2250705
  27. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6.
    Nature. 1991 Jul 25;352(6333):345-7 PMID: 1852210
  28. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease.
    Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8661-5 PMID: 1924327
  29. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes.
    Cell. 1991 Nov 29;67(5):879-88 PMID: 1835668
  30. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship.
    Cell. 1991 Nov 29;67(5):889-99 PMID: 1959134
  31. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
    Nature. 1992 Mar 19;356(6366):215-21 PMID: 1552940
  32. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.
    Proc Natl Acad Sci U S A. 1992 May 15;89(10):4495-9 PMID: 1584781
  33. Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes.
    Blood. 1994 Jul 15;84(2):440-5 PMID: 8025271
  34. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system.
    Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9238-42 PMID: 7937747
  35. Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53.
    FEBS Lett. 1995 Dec 27;377(3):295-300 PMID: 8549741
  36. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
    Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7262-6 PMID: 1353891
  37. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia.
    Genes Dev. 1992 Sep;6(9):1608-20 PMID: 1516826
  38. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.
    Cell. 1992 Nov 13;71(4):587-97 PMID: 1423616
  39. Identification of a ten-amino acid proline-rich SH3 binding site.
    Science. 1993 Feb 19;259(5098):1157-61 PMID: 8438166
  40. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit.
    Genes Dev. 1993 Apr;7(4):555-69 PMID: 8384581
  41. p53 is required for radiation-induced apoptosis in mouse thymocytes.
    Nature. 1993 Apr 29;362(6423):847-9 PMID: 8479522
  42. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53.
    Oncogene. 1993 Jun;8(6):1495-500 PMID: 8502475
  43. Mammalian Ras interacts directly with the serine/threonine kinase Raf.
    Cell. 1993 Jul 16;74(1):205-14 PMID: 8334704
  44. SH3 domains direct cellular localization of signaling molecules.
    Cell. 1993 Jul 16;74(1):83-91 PMID: 8334708
  45. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.
    Cell. 1993 Aug 27;74(4):597-608 PMID: 8358789
  46. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.
    Cell. 1993 Aug 27;74(4):609-19 PMID: 8358790
  47. Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes.
    J Immunol. 1993 Sep 1;151(5):2546-54 PMID: 8360476
  48. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice.
    Science. 1993 Sep 17;261(5128):1584-8 PMID: 8372353
  49. Bcl-2 functions in an antioxidant pathway to prevent apoptosis.
    Cell. 1993 Oct 22;75(2):241-51 PMID: 7503812
  50. Clinical implications of the p53 tumor-suppressor gene.
    N Engl J Med. 1993 Oct 28;329(18):1318-27 PMID: 8413413
  51. Bcl-2 associates with the ras-related protein R-ras p23.
    Nature. 1993 Nov 18;366(6452):274-5 PMID: 8232588
  52. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
    Cell. 1993 Nov 19;75(4):805-16 PMID: 8242751
  53. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  54. Distinct roles for cyclin-dependent kinases in cell cycle control.
    Science. 1993 Dec 24;262(5142):2050-4 PMID: 8266103
  55. Developmental switches in the immune system.
    Cell. 1994 Jan 28;76(2):207-18 PMID: 8293459
  56. Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells.
    Blood. 1994 Apr 15;83(8):2261-7 PMID: 8161792
  57. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.
    Nature. 1994 May 26;369(6478):321-3 PMID: 8183370
  58. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways.
    Oncogene. 1994 Jun;9(6):1791-8 PMID: 8183578
  59. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.
    Oncogene. 1994 Jun;9(6):1799-805 PMID: 8183579
  60. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins.
    Cell. 1994 Oct 21;79(2):341-51 PMID: 7954800
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1996-07-00
Pages
3884-92
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC231385
Subset
IM
Grants
NCI NIH HHS · CA42971 · United States
Databases
GENBANK
U58334
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com